Evidence map›Paper›PMID 30974015›Full record

GuidelineJournal of veterinary internal medicine2019

ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs.

Bruce W Keene, Clarke E Atkins, John D Bonagura, Philip R Fox, Jens Häggström, Virginia Luis Fuentes, Mark A Oyama, John E Rush, Rebecca Stepien, Masami Uechi

Abstract readGuideline
In one paragraph

Guideline in Journal of veterinary internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 404 papers.

0numbers the graph read from it
0cells of the map it votes in
404citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

404 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

344 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bruce W KeeneDepartment of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina.ORCID https://orcid.org/0000-0002-4758-5654
Clarke E AtkinsDepartment of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina.
John D BonaguraDepartment of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina.
Philip R FoxThe Elmer and Mamdouha Bobst Hospital, The Animal Medical Center, New York, New York.ORCID https://orcid.org/0000-0003-4089-0573
Jens HäggströmDepartment of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.ORCID https://orcid.org/0000-0003-3402-023X
Virginia Luis FuentesDepartment of Clinical Science and Services, Royal Veterinary College, London, United Kingdom.
Mark A OyamaDepartment of Clinical Sciences and Advanced Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
John E RushDepartment of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts.ORCID https://orcid.org/0000-0002-8277-8996
Rebecca StepienDepartment of Medical Sciences, University of Wisconsin, Madison, Wisconsin.
Masami UechiJasmine Veterinary Cardiovascular Medical Center, Yokohama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report, issued by the ACVIM Specialty of Cardiology consensus panel, revises guidelines for the diagnosis and treatment of myxomatous mitral valve disease (MMVD, also known as endocardiosis and degenerative or chronic valvular heart disease) in dogs, originally published in 2009. Updates were made to diagnostic, as well as medical, surgical, and dietary treatment recommendations. The strength of these recommendations was based on both the quantity and quality of available evidence supporting diagnostic and therapeutic decisions. Management of MMVD before the onset of clinical signs of heart failure has changed substantially compared with the 2009 guidelines, and new strategies to diagnose and treat advanced heart failure and pulmonary hypertension are reviewed.

Indexed as

AnimalsDog DiseasesDogsHeart FailureHypertension, PulmonaryMitral Valve Insufficiencycaninecongestive heart failureevidence-based treatmentmitral

Identifiers

PMID30974015
PMCPMC6524084

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.